Merck offers a 4.2% dividend yield but faces uncertainty with KEYTRUDA's LOE. Click here to find out why MRK stock is a Hold.

Mature overall survival results of the INAVO120 trial were presented in a press conference for the American Society of ...

Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Merck & Co. is undervalued with strong oncology growth, key R&D investments, and shareholder returns. Click here to read an ...

ZoomRx polled 50 experienced oncologists and hemato-oncologists about 20 cancer drugmakers, asking the doctors to rank the ...

The stock's fall snapped a four-day winning streak.

Those two descriptions definitely apply to the healthcare sector. People need healthcare products and services regardless of ...

Today, Benzinga 's options scanner spotted 33 uncommon options trades for Merck & Co. This isn't normal. The overall ...

Pfizer will pay China’s 3SBio $1.25 billion up front to access a cancer drug that could rival Akeso and Summit’s closely ...

At ITF World 2025, imec and Merck have announced a strategic partnership to develop an advanced MicroPhysiological Systems ...

Pfizer will pay $1.25 billion upfront to license an experimental cancer drug out of China, in a deal that underscores ...

Merck Animal Health is investing $895 million in a De Soto new facility, which will bring hundreds of jobs. It’s a huge ...